Total Funding
45
17
Total FundingSeed raised
Growth Score 45 in past quarter
-4 pts
Heat Score 17 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1082187
EndoInSight produces a disposable CO2 insufflator that gives clinicians a cost-effective alternative to compressed-gas insufflation systems.
About the Company
EndoInSight was founded to help reduce the terrible toll Colorectal Cancer (CRC) takes on society by providing clinicians with a cost-effective method for reducing the pain and discomfort associated with colonoscopy-based CRC screening.
While inflating the colon is necessary to enhance visibility during colonoscopy, trapped air can leave
patients feeling bloated and uncomfortable for hours following their procedure. It has long been known that using CO2 to inflate the colon can dramatically reduce post-procedural pain and discomfort yet adoption of the technique has been slow due to a lack of awareness concerning the benefits of CO2 and the capital expenditure related with current CO2 insufflation systems.
